Plain-English translation of NCT07064018 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new chemotherapy drug called to see if it can help people with advanced cancers that have stopped responding to other treatments. The medication is being tested at different dose levels to find the safest and most effective amount. The trial includes people with soft-tissue sarcoma, triple-negative breast cancer, non-small cell lung cancer, cervical cancer, ovarian cancer, and pancreatic cancer with a KRAS mutation.
Standard chemotherapy drugs can have serious side effects and don't always work well for all cancers. This trial exists to see if this new treatment, which is designed differently from traditional chemotherapy, can work better and be safer for people whose cancers have become resistant to other treatments.
You likely qualify if…
You likely don't qualify if…
You would receive the medication as an injection on day 1 of each 21-day cycle, for a total of 6 cycles (about 4.5 months of treatment). Depending on which dose level you are assigned to, you may also receive injections of a supportive medication to help protect your blood cells. You will have regular blood tests and scans to monitor how well the treatment is working and to watch for any side effects. The trial will help doctors figure out the best dose of this medication to use in future studies.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States